Sanofi ADR (SNY)
Official siteHEALTHCARE • DRUG MANUFACTURERS - GENERAL • NASDAQ
Market Cap: $116.15B
Last updated: Nov 17, 2026 at 4:19 PM ET
Sanofi ADR (SNY) Statistics
Sanofi ADR (SNY) has a market cap of $116.15B. Revenue grew 20.98% over the last 12 months from the 12 months before. Its dividend yield is 5.10%.
Total Valuation
| Market Cap | $116.15B |
|---|---|
| Latest price (Nov 17, 2026) | $47.53 |
Key Dates
The last ex-dividend date was May 4, 2026.
| Last Earnings Date | Oct 30, 2026 |
|---|---|
| Last Ex-Dividend Date | May 4, 2026 |
| Last Payment Date | Jun 3, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 1.9x and 1.4x. Its year-end P/S ranged from 2.2x to 3.0x from 2016 to 2025.
| P/S Ratio | 1.9x |
|---|---|
| P/B Ratio | 1.4x |
| P/TBV Ratio | 19.2x |
Price Statistics
The stock is down 3.75% over 52 weeks and trades 10.92% above its 50-day average.
| Beta (1Y) | 0.26 |
|---|---|
| 52-Week Change | -3.75% |
| 1-Month Change | +20.12% |
| 3-Month Change | +3.71% |
| 6-Month Change | +9.14% |
| 5-Year Change | -12.08% |
| 10-Year Change | +14.01% |
| Total Return (1Y) | +1.16% |
| Total Return (3Y CAGR) | +5.11% |
| Total Return (5Y CAGR) | +3.27% |
| Return vs SPY (1Y) | -12.49% |
| Max Drawdown (1Y) | -20.23% |
| Max Drawdown (3Y) | -27.40% |
| Sharpe Ratio (1Y) | -0.04 |
| Correlation with SPY (1Y) | 0.16 |
| 50-Day Average | $42.85 |
| 200-Day Average | $43.61 |
| 52-Week Range | $39.07 to $48.98 |
| RSI (14 Days) | 67.3 |
| Average Volume (20 Days) | 4.32M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.12x current liabilities, and total debt is 0.25x shareholder equity.
| Current Ratio | 1.12x |
|---|---|
| Quick Ratio | 0.27x |
| Debt / Equity | 0.25x |
| Debt / EBITDA | 1.14x |
| Interest Coverage | 12.17x |
Returns and Efficiency
Return on invested capital is 7.58% over the last 12 months, against a 5-year average of 6.82%.
| Return on Equity (ROE) | 5.74% |
|---|---|
| Return on Assets (ROA) | 3.21% |
| Return on Invested Capital (ROIC) | 7.58% |
| Return on Capital Employed (ROCE) | 9.53% |
| ROE (5Y Average) | 9.13% |
| ROA (5Y Average) | 5.28% |
| ROIC (5Y Average) | 6.82% |
| Asset Turnover | 0.39x |
| Inventory Turnover | 0.55x |
| Receivables Turnover | 10.77x |
| Cash Conversion Cycle | 47 days |
Taxes
Income tax took 29.06% of pretax income over the last 12 months.
| Income Tax (TTM) | EUR 1.72B |
|---|---|
| Effective Tax Rate | 29.06% |
Scores
SNY has an Altman Z-Score of 1.73, in the distress zone below 1.81, and a Piotroski F-Score of 7 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 1.73 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 7 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue was EUR 50.98B over the last 12 months.
| Revenue | EUR 50.98B |
|---|---|
| Revenue Growth (YoY) | +20.98% |
| Gross Profit | EUR 37.56B |
| Operating Income | EUR 8.32B |
| Pretax Income | EUR 5.91B |
| Net Income | EUR 4.18B |
| EBITDA | EUR 15.56B |
| EBIT | EUR 9.58B |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 55.94% of the EUR 130.29B in total assets.
| Working Capital | EUR 3.44B |
|---|---|
| Shareholder Equity | EUR 72.88B |
| Tangible Book Value | EUR 5.25B |
| Total Assets | EUR 130.29B |
| Total Liabilities | EUR 57.05B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After EUR 4.00B of capital spending, operating cash flow left EUR 10.42B of free cash flow.
| Operating Cash Flow | EUR 14.42B |
|---|---|
| Capital Expenditures | EUR 4.00B |
| Free Cash Flow | EUR 10.42B |
| Depreciation and Amortization | EUR 6.33B |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 16.32%, against a 5-year average of 19.89%.
| Gross Margin | 73.68% |
|---|---|
| Operating Margin | 16.32% |
| Pretax Margin | 11.59% |
| Net Margin | 8.19% |
| EBITDA Margin | 30.52% |
| EBIT Margin | 18.79% |
| FCF Margin | 20.43% |
| Gross Margin (5Y Average) | 70.27% |
| Operating Margin (5Y Average) | 19.89% |
| Net Margin (5Y Average) | 15.76% |
Growth
Revenue grew 4.82% a year over 3 years.
| Revenue Growth (3Y CAGR) | +4.82% |
|---|---|
| Revenue Growth (5Y CAGR) | +4.57% |
| FCF Growth (3Y CAGR) | -4.67% |
| FCF Growth (5Y CAGR) | +6.21% |
| Operating Income Growth (3Y CAGR) | -1.89% |
Dividends and Yields
SNY pays out 35.11% of earnings as dividends.
| Dividend Per Share (Annual) | $2.42 |
|---|---|
| Dividend Yield | 5.10% |
| Payment Schedule | Annual |
| Dividend Growth (3Y CAGR) | +7.91% |
| Dividend Growth (5Y CAGR) | +4.60% |
| Payout Ratio | 35.11% |
Peer Position
Against 12 similar companies, SNY has the lowest P/S and the 2nd highest dividend yield.
P/S RatioPeer median 4.9x
ROICPeer median 13.95%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +5.31%
Dividend YieldPeer median 2.37%
| P/S Ratio | 1.9x vs 4.9x median |
|---|---|
| ROIC | 7.58% vs 13.95% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +20.98% vs +5.31% median |
| Dividend Yield | 5.10% vs 2.37% median |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About SNY
What is SNY's market cap?
Sanofi ADR has a market cap of $116.15B.
How many shares of SNY are outstanding?
Sanofi ADR has 2.40B shares outstanding. The count is down 2.75% from a year earlier.
Does SNY pay a dividend?
Yes. Sanofi ADR pays $2.42 a share a year, a dividend yield of 5.10%.
SNY pages: Overview, Dividends, Charting, Financials, Statistics, Valuation, Competitors, Government Contracts